首页> 美国卫生研究院文献>other >Immunoassay and molecular methods to investigate DNA methylation changes in peripheral blood mononuclear cells in HIV infected patients on cART
【2h】

Immunoassay and molecular methods to investigate DNA methylation changes in peripheral blood mononuclear cells in HIV infected patients on cART

机译:在cART上研究HIV感染患者外周血单个核细胞DNA甲基化变化的免疫测定和分子方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study aimed to investigate the influence of antiretroviral therapy on methylation markers, in a group of HIV infected, heavily treated patients. Immune and molecular methods were used to investigate potential changes in methylation profile in DNA isolated from peripheral blood mononuclear cells collected from antiretroviral-experienced HIV infected patients and healthy controls. The percentage of 5-methylcytosine was inversely correlated with proviral DNA and active replication while DNMT1 (p=0.01) and DNMT3A (p=0.004) independently correlated with active viral replication. DNMT3A expression increased with total treatment duration (p=0.03), number of antiretroviral drugs ever used (p=0.003) and cumulative exposure to protease inhibitors (p=0.02) even in currently HIV undetectable patients.
机译:这项研究旨在调查抗逆转录病毒疗法对一组感染了HIV的重症患者的甲基化标志物的影响。使用免疫和分子方法研究了从抗逆转录病毒感染的HIV感染患者和健康对照组收集的外周血单个核细胞中分离的DNA中甲基化谱的潜在变化。 5-甲基胞嘧啶的百分比与原病毒DNA和活性复制呈负相关,而DNMT1(p = 0.01)和DNMT3A(p = 0.004)独立与活性病毒复制相关。 DNMT3A表达随着总治疗持续时间(p = 0.03),曾经使用过的抗逆转录病毒药物的数量(p = 0.003)和蛋白酶抑制剂的累积暴露量(p = 0.02)而增加,即使在目前无法检测到HIV的患者中也是如此。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号